article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

85% of accelerated approvals from 2010 to 2020 were for oncology indications. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. of approvals), cancer (35.6%), and other rare diseases (24.7%). .” of approvals), cancer (35.6%), and other rare diseases (24.7%).

Patients 200
article thumbnail

Top 10 Best Telemedicine Companies in the USA

Medico Reach

Understandably, almost 30% of Americans skipped all doctor visits last year, given the spiraling price of healthcare and the increasing complexity of our daily lives. Physicians and patients continue to have a very positive opinion of the organization. Doctor on Demand Headquarters: San Francisco, California Revenue: $75.9

Doctors 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars. Further, there remains scepticism on the efficacy and safety of biosimilars.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

But, even without Amedisys, the insurer still has home healthcare company LHC Group, acquired in early 2023, and will leverage a long-term partnership with Walmart plus the nation’s largest network of employed and affiliated physicians through Optum to manage patient health and drive down costs for vulnerable patients.

Retail 52
article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.

article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.

article thumbnail

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Medgadget

In 2010, I served as General Manager for the $1.4B Estrampes: The COVID-19 pandemic led to an influx of patients, both for treatment of the virus and for those whose conditions stem from delayed regular doctor visits and exams due to the pandemic. Administrative responsibilities are a huge contributor to physician burnout.